Activation of this pathway is considered a potential therapeutic approach to inhibiting synovial inflammation and pannus neovascularization in RA [28], suggesting that the PPAR signaling pathway exhibits different effects in different cells. The gene discussed is PPARA; the disease is rheumatoid arthritis.